---
title: "Switching to ARNI Associated with Lower Short-Term New-Onset Atrial Fibrillation in HFrEF"
id: "pubmed-42740677"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-42740677"
content_type: "clinical_feed_article"
specialty: "Cardiology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/42740677/"
doi: "10.1093/ehjcvp/pvag074"
published_at: "2026-11-04T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Switching to ARNI Associated with Lower Short-Term New-Onset Atrial Fibrillation in HFrEF
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-42740677
- **Specialty:** [Cardiology](https://medichelpline.com/clinical-feed/cardiology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/42740677/)
- **DOI:** [10.1093/ehjcvp/pvag074](https://doi.org/10.1093%2Fehjcvp%2Fpvag074)
- **Published At:** 2026-11-04T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- Investigators used the Korean National Health Insurance Service database (2017–2021) to evaluate AF incidence after switching to an angiotensin receptor–neprilysin inhibitor (**ARNI**) versus continuing traditional **renin–angiotensin system** (RAS) blockade in patients with heart failure with reduced ejection fraction (**HFrEF**) and no prior atrial fibrillation. - The initial sample included 39,061 HFrEF patients without prior AF: 12,263 received ARNI and 26,798 received traditional RAS blockade. - The study team performed 1:1 propensity score matching, yielding 9,030 patients in each treatment arm for the primary comparative analyses. - The primary outcome was **new-onset atrial fibrillation** within one year after treatment assignment. - In the matched cohort, the ARNI group had a lower new-onset AF incidence (10.73 vs. 12.15 per 100 person-years) and a hazard ratio (HR) of 0.89 (95% CI 0.81–0.98; P = 0.021) versus continued RAS blockade. - A composite endpoint of new-onset AF, ischaemic stroke, or all-cause death was reduced with ARNI (HR 0.85; 95% CI 0.79–0.92; P < 0.001) in the matched cohort. - Competing risk analysis produced a subdistribution hazard ratio (sHR) for new-onset AF of 0.73 (95% CI 0.58–0.91; P = 0.005) favoring ARNI. - In the unmatched cohort, exploratory adjustment for selected covariates (age, sex, hypertension, chronic kidney disease, prior ischaemic stroke, socioeconomic status, residential region, beta-blocker use) yielded an HR of 0.85 (95% CI 0.75–0.96); however, full adjustment for all measured baseline covariates produced an HR of 0.94 (95% CI 0.87–1.02). - The study was retrospective and observational; authors noted that prospective studies are required to confirm the association observed. - Conflict of interest: None declared.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/42740677/#article-details) ### NIH Websites Are Changing * [Get the Latest Updates and FAQs on the transition](https://www.nih.gov/web-modernization) * Per [Executive Order 14434](https://www.whitehouse.gov/presidential-actions/2026/09/inaugurating-the-era-of-super-intelligence/), federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition. ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42740677%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/42740677/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/42740677/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/42740677/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/42740677/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/42740677/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/42740677/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42740677%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F42740677%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/42740677/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42740677/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42740677/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/42740677/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Full text links [![Silverchair Information Systems full text link](https://cdn.ncbi.nlm.nih.gov/corehtml/query/egifs/https:--academic.oup.com-images-oup_pubmed_free.png) Silverchair Information Systems ](https://academic.oup.com/ehjcvp/article-lookup/doi/10.1093/ehjcvp/pvag074 "See full text options at Silverchair Information Systems") [ Full text links ](https://pubmed.ncbi.nlm.nih.gov/42740677/) ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/42740677/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/42740677/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/42740677/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/42740677/#conflict-of-interest) * [Similar articles](https://pubmed.ncbi.nlm.nih.gov/42740677/#similar) * [ Publication types ](https://pubmed.ncbi.nlm.nih.gov/42740677/#publication-types) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/42740677/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/42740677/#substances) * [Related information](https://pubmed.ncbi.nlm.nih.gov/42740677/#related-links) * [ Grants and funding ](https://pubmed.ncbi.nlm.nih.gov/42740677/#grants) * [ LinkOut - more resources ](https://pubmed.ncbi.nlm.nih.gov/42740677/#linkout) Title & authors Abstract Conflict of interest statement Similar articles Publication types MeSH terms Substances Related information Grants and funding LinkOut - more resources Observational Study Eur Heart J Cardiovasc Pharmacother Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Eur+Heart+J+Cardiovasc+Pharmacother%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Eur+Heart+J+Cardiovasc+Pharmacother%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42740677/) . 2026 Nov 4;12(7):535-545. doi: 10.1093/ehjcvp/pvag074. # Switching to angiotensin receptor-neprilysin inhibitor and reduced risk of new-onset atrial fibrillation in heart failure with reduced ejection fraction: a nationwide propensity score-matched study [Young Jun Park](https://pubmed.ncbi.nlm.nih.gov/?term=Park+YJ&cauthor_id=42740677)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42740677/#full-view-affiliation-1 "Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul 02841, South Korea."), [Dong-Hyuk Cho](https://pubmed.ncbi.nlm.nih.gov/?term=Cho+DH&cauthor_id=42740677)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42740677/#full-view-affiliation-1 "Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul 02841, South Korea."), [Jimi Choi](https://pubmed.ncbi.nlm.nih.gov/?term=Choi+J&cauthor_id=42740677)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42740677/#full-view-affiliation-2 "Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul 02841, South Korea."), [Jong-Chan Youn](https://pubmed.ncbi.nlm.nih.gov/?term=Youn+JC&cauthor_id=42740677)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42740677/#full-view-affiliation-3 "Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, Catholic Research Institute for Intractable Cardiovascular Disease, College of Medicine, Catholic University of Korea, Seoul 06591, South Korea."), [Mi-Na Kim](https://pubmed.ncbi.nlm.nih.gov/?term=Kim+MN&cauthor_id=42740677)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42740677/#full-view-affiliation-1 "Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul 02841, South Korea."), [Chan Joo Lee](https://pubmed.ncbi.nlm.nih.gov/?term=Lee+CJ&cauthor_id=42740677)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42740677/#full-view-affiliation-4 "Division of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, South Korea."), [Jung-Woo Son](https://pubmed.ncbi.nlm.nih.gov/?term=Son+JW&cauthor_id=42740677)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42740677/#full-view-affiliation-5 "Division of Cardiology, Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju 26426, South Korea."), [Byung-Su Yoo](https://pubmed.ncbi.nlm.nih.gov/?term=Yoo+BS&cauthor_id=42740677)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42740677/#full-view-affiliation-5 "Division of Cardiology, Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju 26426, South Korea.") Affiliations Expand ### Affiliations * 1 Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul 02841, South Korea. * 2 Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul 02841, South Korea. * 3 Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, Catholic Research Institute for Intractable Cardiovascular Disease, College of Medicine, Catholic University of Korea, Seoul 06591, South Korea. * 4 Division of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, South Korea. * 5 Division of Cardiology, Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju 26426, South Korea. * PMID: **42740677** * DOI: [ 10.1093/ehjcvp/pvag074 ](https://doi.org/10.1093/ehjcvp/pvag074) Free article Item in Clipboard Observational Study # Switching to angiotensin receptor-neprilysin inhibitor and reduced risk of new-onset atrial fibrillation in heart failure with reduced ejection fraction: a nationwide propensity score-matched study Young Jun Park et al. Eur Heart J Cardiovasc Pharmacother. 2026. Free article Show details Display options Display options Format Abstract PubMed PMID Eur Heart J Cardiovasc Pharmacother Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Eur+Heart+J+Cardiovasc+Pharmacother%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Eur+Heart+J+Cardiovasc+Pharmacother%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/42740677/) . 2026 Nov 4;12(7):535-545. doi: 10.1093/ehjcvp/pvag074. ### Authors [Young Jun Park](https://pubmed.ncbi.nlm.nih.gov/?term=Park+YJ&cauthor_id=42740677)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42740677/#short-view-affiliation-1 "Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul 02841, South Korea."), [Dong-Hyuk Cho](https://pubmed.ncbi.nlm.nih.gov/?term=Cho+DH&cauthor_id=42740677)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42740677/#short-view-affiliation-1 "Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul 02841, South Korea."), [Jimi Choi](https://pubmed.ncbi.nlm.nih.gov/?term=Choi+J&cauthor_id=42740677)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/42740677/#short-view-affiliation-2 "Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul 02841, South Korea."), [Jong-Chan Youn](https://pubmed.ncbi.nlm.nih.gov/?term=Youn+JC&cauthor_id=42740677)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/42740677/#short-view-affiliation-3 "Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, Catholic Research Institute for Intractable Cardiovascular Disease, College of Medicine, Catholic University of Korea, Seoul 06591, South Korea."), [Mi-Na Kim](https://pubmed.ncbi.nlm.nih.gov/?term=Kim+MN&cauthor_id=42740677)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/42740677/#short-view-affiliation-1 "Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul 02841, South Korea."), [Chan Joo Lee](https://pubmed.ncbi.nlm.nih.gov/?term=Lee+CJ&cauthor_id=42740677)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/42740677/#short-view-affiliation-4 "Division of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, South Korea."), [Jung-Woo Son](https://pubmed.ncbi.nlm.nih.gov/?term=Son+JW&cauthor_id=42740677)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42740677/#short-view-affiliation-5 "Division of Cardiology, Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju 26426, South Korea."), [Byung-Su Yoo](https://pubmed.ncbi.nlm.nih.gov/?term=Yoo+BS&cauthor_id=42740677)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/42740677/#short-view-affiliation-5 "Division of Cardiology, Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju 26426, South Korea.") ### Affiliations * 1 Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul 02841, South Korea. * 2 Division of Endocrinology and Metabolism, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul 02841, South Korea. * 3 Division of Cardiology, Department of Internal Medicine, Seoul St. Mary's Hospital, Catholic Research Institute for Intractable Cardiovascular Disease, College of Medicine, Catholic University of Korea, Seoul 06591, South Korea. * 4 Division of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, South Korea. * 5 Division of Cardiology, Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju 26426, South Korea. * PMID: **42740677** * DOI: [ 10.1093/ehjcvp/pvag074 ](https://doi.org/10.1093/ehjcvp/pvag074) Item in Clipboard Full text links Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract **Aims:** We investigated whether switching from traditional renin-angiotensin system (RAS) blockade to angiotensin receptor-neprilysin inhibitor (ARNI) is associated with a lower risk of new-onset atrial fibrillation (AF) than continuing RAS blockade in patients with heart failure with reduced ejection fraction (HFrEF) without prior AF. **Methods and results:** Using data from the Korean National Health Insurance Service (2017-2021), we identified 39 061 patients with HFrEF without prior AF who received either ARNI (n = 12 263) or traditional RAS blockade (n = 26 798). After 1:1 propensity score matching, 9030 patients were included in each group. The primary outcome was new-onset AF within 1 year. In the propensity score-matched cohort, new-onset AF incidence was lower in the ARNI group [10.73 vs. 12.15 per 100 person-years; hazard ratio (HR) 0.89; 95% confidence interval (CI) 0.81-0.98; P = 0.021]. The composite outcome (new-onset AF, ischaemic stroke, or all-cause death) was also reduced (HR 0.85; 95% CI 0.79-0.92; P < 0.001). In competing risk analysis, ARNI was associated with a lower subdistribution hazard of new-onset AF (sHR 0.73; 95% CI 0.58-0.91; P = 0.005). In the unmatched cohort, the HR was 0.85 (95% CI 0.75-0.96) in an exploratory model including age, sex, hypertension, chronic kidney disease, prior ischaemic stroke, socioeconomic status, residential region, and beta-blocker use, and 0.94 (95% CI 0.87-1.02) after adjustment for all measured baseline covariates. **Conclusion:** In this large nationwide cohort of AF-naive patients with HFrEF, switching to ARNI was associated with a lower risk of short-term new-onset AF than continuing traditional RAS blockade. As this was a retrospective study, further prospective studies are needed to confirm these findings. **Keywords:** Angiotensin receptor–neprilysin inhibitor; Atrial fibrillation; Heart failure with reduced ejection fraction; Real-world evidence; Renin–angiotensin system blockade. © The Author(s) 2026. Published by Oxford University Press on behalf of European Society of Cardiology. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Conflict of interest statement Conflict of interest: None declared. ## Similar articles * [ Effectiveness of angiotensin-neprilysin inhibitor treatment versus renin-angiotensin system blockade in older adults with heart failure in clinical care. ](https://pubmed.ncbi.nlm.nih.gov/34088766/) Desai RJ, Patorno E, Vaduganathan M, Mahesri M, Chin K, Levin R, Solomon SD, Schneeweiss S.Desai RJ, et al.Heart. 2021 Sep;107(17):1407-1416. doi: 10.1136/heartjnl-2021-319405. Epub 2021 Jun 4.Heart. 2021.PMID: 34088766 * [ Angiotensin receptor-neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure. ](https://pubmed.ncbi.nlm.nih.gov/40608018/) Jung MH, Cho DH, Choi J, Kim MN, Lee CJ, Son JW, Kim Y, Youn JC, Yoo BS.Jung MH, et al.ESC Heart Fail. 2025 Oct;12(5):3405-3415. doi: 10.1002/ehf2.15359. Epub 2025 Jul 3.ESC Heart Fail. 2025.PMID: 40608018Free PMC article. * [ Real-World Experience of Angiotensin Receptor-Neprilysin Inhibition in Reduced Ejection Fraction Heart Failure Patients With Advanced Kidney Disease. ](https://pubmed.ncbi.nlm.nih.gov/36109207/) Chang HY, Lin CC, Chao CJ, Lin YC, Wang YC, Liao CT, Huang JL, Lee YH, Huang CY, Chien LN, Hsu CY.Chang HY, et al.Mayo Clin Proc. 2023 Jan;98(1):88-99. doi: 10.1016/j.mayocp.2022.06.007. Epub 2022 Sep 13.Mayo Clin Proc. 2023.PMID: 36109207 * [ Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction. ](https://pubmed.ncbi.nlm.nih.gov/29952095/) Martin N, Manoharan K, Thomas J, Davies C, Lumbers RT.Martin N, et al.Cochrane Database Syst Rev. 2018 Jun 28;6(6):CD012721. doi: 10.1002/14651858.CD012721.pub2.Cochrane Database Syst Rev. 2018.Update in: [Cochrane Database Syst Rev. 2021 May 22;5:CD012721. doi: 10.1002/14651858.CD012721.pub3.](https://pubmed.ncbi.nlm.nih.gov/34022072/)PMID: 29952095Free PMC article.Updated. * [ Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction. ](https://pubmed.ncbi.nlm.nih.gov/34022072/) Martin N, Manoharan K, Davies C, Lumbers RT.Martin N, et al.Cochrane Database Syst Rev. 2021 May 22;5(5):CD012721. doi: 10.1002/14651858.CD012721.pub3.C
## Related Clinical Research

- [Comparing BMI, Waist Circumference, and BRI for Predicting ASCVD, AF, and Mortality in 1.2M Koreans](https://medichelpline.com/clinical-feed/plos-one-14-prognostic-associations-of-anthropometric-indices-with-major-health-outcomes-a.md)
- [Cardiovascular risk and mortality after statin initiation: achieved LDL and non‑HDL levels in a 3‑](https://medichelpline.com/clinical-feed/plos-medicine-0-risk-of-cardiovascular-events-and-mortality-associated-with-ldl-and-non-hdl.md)
- [ZEUS trial: IL-6 blocker ziltivekimab lowered inflammation but did not cut major CV events](https://medichelpline.com/clinical-feed/aha-news-1-researchers-say-inflammation-as-a-treatment-target-still-important-despite.md)
- [GLP-1 drugs tied to lower diabetes progression and cardiovascular events than metformin](https://medichelpline.com/clinical-feed/aha-news-4-glp-1-meds-linked-to-lower-diabetes-heart-risks-than-standard-diabetes.md)
- [Cardiovascular risk prediction models in women: protocol for an updated systematic review](https://medichelpline.com/clinical-feed/plos-one-7-cardiovascular-risk-prediction-models-for-women-a-systematic-review-protocol.md)

## Navigation
- [← Back to Cardiology Feed](https://medichelpline.com/clinical-feed/cardiology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.